Piramal Enterprises will receive $140 million in FY26 from the sale of Life Molecular Imaging Ltd, with potential future earnouts up to $200 million. Shares rose 7.5% on the announcement.
Piramal Enterprises will receive $140 million in FY26 from the sale of Life Molecular Imaging Ltd, with potential future earnouts up to $200 million. Shares rose 7.5% on the announcement.